Published

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104: A Double-Blind, Randomized, Single Ascending Dose Placebo-Controlled Study.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Unknown
Date: 2025-07-19
Source: Europe PMC
DOI: 10.1097/jcp.0000000000002047
PubMed: 40685873

Authors

Ludbrook G Bryson N Taylor B Hocevar-Trnka J Johnson MW Hirman J Morrish G Alexander R Pollack M.

Watch author

Derived topics and classifications

psilocybin Chronic Pain Pharmacology Mystical Experience Clinical Trial Observational Study Safety Adverse Events Toxicity Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counselingTherapeutic Advances in Drug Safety · 2026-02-28 Opinion Mining of Erowid’s Experience Reports on LSD and Psilocybin-Containing MushroomsDrug Safety · 2025-03-03 Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.Expert Opinion on Drug Safety · 2022-04-26